Tafluprost for the Reduction of Interocular Pressure in Open Angle Glaucoma and Ocular Hypertension

Tafluprost for the Reduction of Interocular Pressure in Open Angle Glaucoma and Ocular Hypertension

Show other versions (1)

Bibliographic Details
Main Author:	Clyde Schultz
Format:	Article
Language:	English
Published:	SAGE Publishing 2011-06-01
Series:	Ophthalmology and Eye Diseases
Online Access:	http://www.la-press.com/tafluprost-for-the-reduction-of-interocular-pressure-in-open-angle-gla-a2714

Similar Items

Tafluprost for the Reduction of Interocular Pressure in Open Angle Glaucoma and Ocular Hypertension
by: Clyde Schultz
Published: (2011-01-01)

Clinical appraisal of tafluprost in the reduction of elevated intraocular pressure (IOP) in open-angle glaucoma and ocular hypertension
by: Makoto Aihara
Published: (2010-03-01)

Safety and tolerability of tafluprost in treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension
by: Dorota Pozarowska
Published: (2010-10-01)

Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in China
by: Xinghuai Sun, et al.
Published: (2022-08-01)

Preservative-free tafluprost in the treatment of naive patients with glaucoma and ocular hypertension
by: Lanzl I, et al.
Published: (2013-05-01)

Tafluprost once daily for treatment of elevated intraocular pressure in patients with open-angle glaucoma
by: Liu Y, et al.
Published: (2012-12-01)

Efficacy and safety of 0.0015% tafluprost versus 0.005% latanoprost in primary open angle glaucoma, ocular hypertension: a Meta-analysis
by: Xi-Ting Yang, et al.
Published: (2020-03-01)

Differential pharmacology and clinical utility of preservative-free tafluprost in the treatment of ocular hypertension and glaucoma
by: Ermiş&nbsp;SS
Published: (2012-05-01)

Treatment of open-angle glaucoma and ocular hypertension with preservative-free tafluprost/timolol fixed-dose combination therapy: 6 case reports and clinical outcomes
by: E. Ansari, et al.
Published: (2022-04-01)

Treatment of Open-Angle Glaucoma and Ocular Hypertension with the Fixed-Dose Combination of Preservative-Free Tafluprost/Timolol: Clinical Outcomes from Ophthalmology Clinics in Italy
by: Oddone F, et al.
Published: (2022-06-01)

Preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% in patients with open-angle glaucoma and ocular hypertension: results of an open-label observational study
by: Pillunat LE, et al.
Published: (2017-06-01)

Ocular Surface Changes After Switching from Other Prostaglandins to Tafluprost and Preservative-Free Tafluprost in Glaucoma Patients
by: Ruangvaravate N, et al.
Published: (2020-10-01)

Correlation of open-angle glaucoma and ocular perfusion pressure in hypertensive individuals
by: Rekha Khandelwal, et al.
Published: (2020-01-01)

Blood pressure, ocular perfusion pressure and open-angle glaucoma in patients with systemic hypertension
by: Cantor E, et al.
Published: (2018-08-01)

24-Hour Evaluation of the Effectiveness and Tolerability of Preservative-Free Tafluprost-Timolol Fixed Combination in Open-Angle Glaucoma or Ocular Hypertensive Patients Previously Treated with Preserved Latanoprost
by: Oddone F, et al.
Published: (2024-06-01)

Effects of preservative-free tafluprost on tear film osmolarity, tolerability, and intraocular pressure in previously treated patients with open-angle glaucoma
by: Janulevičienė I, et al.
Published: (2012-01-01)

The 24-hour intraocular pressure control by tafluprost/timolol fixed combination after switching from the concomitant use of tafluprost and timolol gel-forming solution, in patients with primary open-angle glaucoma
by: Nakamoto K, et al.
Published: (2018-02-01)

OCT angiography analysis of retinal vessel density in primary open-angle glaucoma with and without Tafluprost therapy
by: Hannah Weindler, et al.
Published: (2020-11-01)

Assessment of the optic nerve head, peripapillary, and macular microcirculation in the newly diagnosed patients with primary open-angle glaucoma treated with topical tafluprost and tafluprost/timolol fixed combination
by: Natalia Ivanovna Kurysheva
Published: (2019-01-01)

Comparison of Efficacy and Safety of Latanoprost versus Fixed Combination of Tafluprost and Timolol in Patients with Primary Open-Angle Glaucoma
by: Gentian Hoxha, et al.
Published: (2024-12-01)

Long term safety and tolerability of Tafluprost 0.0015% vs Timolol 0.1% preservative-free in ocular hypertensive and in primary open-angle glaucoma patients: a cross sectional study
by: Teresa Rolle, et al.
Published: (2017-08-01)

Pulsatile Ocular Blood Flow Analysis in Cases with Primary Open-angle Glaucoma, Ocular Hypertension and Normotensive Glaucoma
by: Adem Türk, et al.
Published: (2012-03-01)

Real-World Efficacy and Safety of Tafluprost in Primary Open-Angle Glaucoma Patients with Corneal Disorders: A Taiwan Experience
by: Ju-Kuo Lin, et al.
Published: (2022-01-01)

Additive Intraocular Pressure Lowering Effects of Ripasudil in Patients with Primary Open Angle Glaucoma and Ocular Hypertension
by: Asma Jabeen, et al.
Published: (2024-01-01)

Spectral analysis of intraocular pressure pulse wave in ocular hypertensive and primary open angle glaucoma patients
by: Marija M Bozic, et al.
Published: (2016-01-01)

Comparison study of intraocular pressure reduction efficacy and safety between latanoprost and tafluprost in Japanese with normal-tension glaucoma
by: Ikeda Y, et al.
Published: (2016-08-01)

Effect of mean ocular perfusion pressure on primary open angle glaucoma
by: Pallab Kumar Sen, et al.
Published: (2018-12-01)

Retinal Blood Flow Velocity Change in Parafoveal Capillary after Topical Tafluprost Treatment in Eyes with Primary Open-angle Glaucoma
by: Yuto Iida, et al.
Published: (2017-07-01)

Ocular Surface Cytotoxicity and Safety Evaluation of Tafluprost, a Recently Developed Anti-Glaucoma Prostaglandin Analog
by: Yoshimi Niwano, et al.
Published: (2014-02-01)

Ocular Surface Cytotoxicity and Safety Evaluation of Tafluprost, a Recently Developed Anti-Glaucoma Prostaglandin Analog
by: Yoshimi Niwano, et al.
Published: (2014-01-01)

The Association of Primary Open Angle Glaucoma and Ocular Hypertension with Anti-VEGF Injections
by: LoBue SA, et al.
Published: (2024-12-01)

Comparison of Efficacy and Ocular Surface Disease Index Score between Bimatoprost, Latanoprost, Travoprost, and Tafluprost in Glaucoma Patients
by: Wissam Georges El Hajj Moussa, et al.
Published: (2018-01-01)

Open angle glaucoma, glaucoma suspect and ocular hypertension in thyroid related immune orbitopathy and other thyroid diseases
by: Saleha Sultana, et al.
Published: (2016-07-01)

Comparison of Newly Diagnosed Ocular Hypertension and Open-Angle Glaucoma: Ocular Variables, Risk Factors, and Disease Severity
by: Yvonne M. Buys, et al.
Published: (2012-01-01)

The clinical effectiveness of tafluprost on Japanese normal-tension glaucoma patients
by: Nomura A, et al.
Published: (2018-03-01)

Hypertension in Primary Open Angle Glaucoma
by: Suprada Pokharel, et al.
Published: (2014-06-01)

Hypertension in Primary Open Angle Glaucoma
by: Suprada Pokharel, et al.
Published: (2014-06-01)

The effect of changes in intraocular pressure on the risk of primary open-angle glaucoma in patients with ocular hypertension: an application of latent class analysis
by: Gao Feng, et al.
Published: (2012-10-01)

Outcome of Selective Laser Trabeculoplasty in Young Patients with Primary Open-Angle Glaucoma and Ocular Hypertension
by: Dan Liu, et al.
Published: (2020-01-01)

Comparison of the Efficacy of Latanoprost, Bimatoprost, and Travoprost in Patients with Primary Open-Angle Glaucoma and Ocular Hypertension
by: Nur Çolak, et al.
Published: (2014-05-01)